Apollomics, Inc. (Nasdaq: APLM) is a clinical-stage biopharmaceutical company headquartered in Foster City, California, focused on the discovery and development of oncology therapies designed to be combined with other treatments to harness the immune system and target specific molecular pathways that inhibit cancer. - View it on GitHub